Abstract
This research service analyses the European Lung cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recommendations.
Table of Contents
1. EXECUTIVE SUMMARY
Overview
- Overview of the European Lung Cancer Therapeutics Markets
2. GLOSSARY OF TERMS
List of Terms
- Abbreviations
3. RESEARCH METHODOLOGY
Research Objectives and Scope
- Methodology
- Assumptions and Limitations
4. MARKET OVERVIEW
Introduction
- Disease Characteristics
- Epidemiology
5. INDUSTRY CHALLENGES
Industry Challenges for the European Lung Cancer Therapeutics Market
- Challenges Faced by Pharmaceutical and Biotech Companies
6. TOTAL EUROPEAN LUNG CANCER THERAPEUTICS MARKET
Overview and Definitions
- Introduction
- Market Drivers
- Market Restraints
- Current Therapeutic Options
- Future Therapeutic Approaches
- Market Engineering Measurement Analysis
Competitive Analysis
- Pipeline Analysis
7. TOTAL FORECASTS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET
Forecasts
- Patient Forecasts
- Market Revenue Forecasts
- Geographical Trends
8. PRICING AND REIMBURSEMENTS
Pricing and Reimbursements Issues
- Pricing and Reimbursements in Europe
9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET
Market Engineering Recommendations
- Strategic Recommendations
10. DATABASE OF KEY INDUSTRY PARTICIPANTS
Key Industry Participants
- Key Participants in the Lung Cancer Therapeutics Market
11. DECISION SUPPORT DATABASES
Habitual Indicators
- Prevalence of Smokers
- Prevalence of Male Smokers
- Prevalence of Female Smokers
- Per Capita Consumption of Cigarette
- Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market
